Solution Temperature for Hysteroscopic Surgery
(STOFD Trial)
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Solution Temperature for Hysteroscopic Surgery is an effective treatment?
The available research shows that using warmed saline during hysteroscopic surgery can reduce pain compared to room temperature saline. Several studies compared pain levels during the procedure and found that patients experienced less discomfort with warmed saline. This suggests that adjusting the temperature of the saline can make the treatment more comfortable for patients, which is an important measure of its effectiveness.12345
What safety data exists for using different temperatures of saline in hysteroscopic surgery?
The studies primarily focus on comparing pain levels, ease of procedure, and patient satisfaction when using saline at different temperatures during hysteroscopy. They suggest that the temperature of the saline can affect procedural discomfort and patient satisfaction, but do not directly address safety concerns. However, they emphasize the importance of careful fluid monitoring regardless of the medium used.12456
Is using different temperatures of 0.9% Saline a promising treatment for hysteroscopic surgery?
Yes, using different temperatures of 0.9% Saline for hysteroscopic surgery can be promising. Studies suggest that warming the saline can improve patient comfort by reducing pain during the procedure. It may also enhance the clarity of the view for doctors, making the surgery easier and potentially more effective.12457
What is the purpose of this trial?
Hysteroscopic surgery is widely used for the treatment of gynecological diseases, such as septum, synechiae, polyp and intrauterine fibroids. The complication rate is estimated as 0.22% and includes uterine perforation, massive bleeding, and fluid overload. Operative hysteroscopy intravascular absorption (OHIA) syndrome refers to fluid overload complications from operative hysteroscopies and is considered a major complication. Report describing the clinical association between irrigation fluid temperature to intravasation rate itself or the risk of fluid overload are limited mainly to theoretical models. Due to the aforementioned, we aim to evaluated the role of temperature on absorption of the irrigation solution in hysteroscopic surgery.
Research Team
Aya Mohr-Sasson
Principal Investigator
The University of Texas Health Science Center, Houston, TX
Eligibility Criteria
This trial is for women undergoing hysteroscopic surgery, a procedure used to treat various gynecological issues. It's open to all women who are scheduled for this type of surgery.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo hysteroscopic surgery with randomly assigned irrigation fluid temperatures
Immediate Post-operative Monitoring
Participants are monitored for immediate post-surgical pain and fluid deficit
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- 0.9% Saline cooled to 17 degrees Celsius
- 0.9% Saline warmed to 24 degrees Celsius
- 0.9% Saline warmed to 37 degrees Celsius
- Hysteroscopic surgery
0.9% Saline cooled to 17 degrees Celsius is already approved in European Union, United States, Canada for the following indications:
- General medical use as a diluent or vehicle for intravenous administration
- Hysteroscopic procedures
- General medical use as a diluent or vehicle for intravenous administration
- Hysteroscopic procedures
- General medical use as a diluent or vehicle for intravenous administration
- Hysteroscopic procedures
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor